ASPEN PHARMACARE HOLDINGS PLC financial statements, including revenue, expenses, and profit
The total revenue of LDZA for the last semiannual is 1.12 B EUR, and it's 7.11% lower compared to the previous semiannual. The net income of H1 25 is 121.34 M EUR.